Secret Talks: The Bloomberg Close, Americas Edition
Good afternoon. Here's what you need to know to end your day. The US and its allies have pressured Israel to delay its ground invasion of Gaza to win the release of hostages held by Hamas. The Fed’s Mester warned that interest-rate hiking campaign could stall if the economy evolves as expected. Meanwhile, a summit in Cairo is expected to include several regional leaders, European foreign ministers, and South Africa’'s Cyril Ramaphosa. Stocks and Treasuries have dropped due to concerns that the conflict will widen. The UN's Antonio Guterres said supplies are the difference between “life and death” for Gaza's more than 2 million people. The Federal Reserve Bank of Cleveland is raising its wage offer to 23%, matching GM and Ford as negotiations with the United Auto Workers heat up.
ที่ตีพิมพ์ : 2 ปีที่แล้ว โดย Victoria Cavaliere ใน Health
Good afternoon. Here's what you need to know to end your day.
• The US and its allies press Israel to delay its invasion of Gaza.
• The Fed’s Mester says rates might be at a holding point.
• Ozempic for kids? Drugmakers will test the weight-loss shots.
US and European governments have been putting pressure on Israel to hold off on its ground invasion of Gaza to try an win the release of hostages held by Hamas, according to people familiar with the efforts.
• Secret talks are under way via Qatar, the people said.
• Hamas, for its part, said it released a woman and her daughter held hostage, both US citizens, “in response to Qatari efforts.”
• Israel has shifted its tone on plans to invade Gaza to try and eradicate Hamas after its Oct. 7 attack, suggesting a more limited approach that might reduce civilian casualties.
• The Rafah crossing—where aid trucks await entry from Egypt to Gaza—remained shut. The UN’s Antonio Guterres said the supplies are the difference between “life and death” for Gaza’s more than 2 million people.
• Amid fears the conflict could widen, a “Summit for Peace” in Cairo tomorrow is expected to include several regional leaders, European foreign ministers and South Africa’s Cyril Ramaphosa.
• Stocks fell and Treasuries rose on concerns the conflict will widen. Oil posted a second weekly gain but dropped after hitting $90 a barrel.
• Follow the latest Mideast developments here and market moves here.
What Else Is Happening
Federal Reserve Bank of Cleveland President Loretta Mester said the US central bank is close to wrapping up its interest-rate hiking campaign to tame inflation if the economy evolves as expected. “We are likely near or at a holding point on the funds rate,” Mester said. Economists raised US growth projections through early 2024 and trimmed recession odds to a one-year low.
Stellantis is raising its wage offer to 23%, matching GM and Ford as negotiations with the United Auto Workers heat up. The offer may not be enough to assuage the UAW, which is now asking for a 25% increase, according to people familiar.
Trump loyalist Jim Jordan lost the Republican nomination for House speaker shortly after he failed during a third ballot for the speakership, with a growing number of GOP lawmakers pulling support. “We’re in a very bad position as a party,” former Speaker Kevin McCarthy said. Rivals are waiting in the wings.
• Before FTX collapsed, Sam Bankman-Fried spent billions of dollars in customer money, prosecutors in his criminal trial allege.
• Volumes on American Express cards slowed more than expected in Q3 as small business and corporations pulled back on spending.
• Mexico’s new state-owned airline has no planes or scheduled flights registered under its name a month before operations are slated to start.
California Governor Gavin Newsom’s latest attempt to reduce homelessness by forcing those who are living on the streets and experiencing mental health issues or a substance use disorder into institutional treatment is bound to fail, Claudia Sahm writes. Homelessness is, at its core, about a lack of affordable housing, not a lack of medical care.
Businessweek explores how inflation at 130% is pushing Argentinian voters down a radical path. Read about how B-schools are grappling with preparing students for a world transformed by AI—and how UBS is doubling down on wealth management and expansion in the US.
By the Way
Ozempic, Mounjaro and other similar diabetes drugs might be all the rage for adults who want or need to shed pounds, and pharmaceutical companies are now looking to get the buzzy weight-loss shots approved for patients as young as six. Some experts believe medication could be a game-changer, particularly as US childhood obesity rates have tripled in the last decade. Other are hesitant because of all the unknowns.